BiotechTube
PredxBio

PredxBio

San Francisco, United States· Est.
predxbio.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3.8M

Overview

PredxBio is a private, early-stage biotech company founded in 2020, headquartered in San Francisco, CA. The company has developed the SpaceIQ™ decision-intelligence platform, which applies explainable AI to spatial multi-omics data to uncover response-driving tissue biology that conventional analyses miss. PredxBio operates as a platform and services company, providing tissue intelligence to biopharma partners to guide target selection, biomarker strategy, and clinical trial optimization. It is currently in a pre-revenue or early-revenue stage, building its commercial presence through events, whitepapers, and business development.

AI / Machine LearningDiagnostics

Technology Platform

SpaceIQ™, a decision-intelligence platform that applies explainable AI to spatial multi-omics data to transform complex tissue data into actionable insights for drug discovery and clinical development.

Funding History

1
Total raised:$3.8M
Seed$3.8M

Opportunities

The rapid growth of spatial biology and AI in life sciences creates a large addressable market.
Biopharma's urgent need to improve R&D productivity and de-risk clinical trials drives demand for actionable tissue intelligence.
The company's focus on explainable AI addresses a key industry barrier to adoption for critical decision-making.

Risk Factors

Intense competition from both established tools companies and AI-native startups.
The challenge of integrating an external AI platform into the core, regulated decision-making workflows of risk-averse biopharma clients.
Dependency on securing large-scale partnerships and demonstrating clear ROI to achieve scalable revenue.

Competitive Landscape

PredxBio competes in a crowded landscape including spatial data generation companies (10x Genomics, Akoya, NanoString) adding analytics, pure-play AI/biotech firms (e.g., Recursion, Insitro, PathAI), and large cloud/AI providers (Google, AWS, IBM). Its differentiation lies in combining explainable AI with a focus on spatial multi-omics specifically for clinical development decision support.

More companies in AI / Machine Learning →More companies in United States →